Insmed Shares Are Trading Higher After Wells Fargo Maintained an Overweight Rating on the Stock and Maintained Its Price Target of $55
在富国银行维持对该股的增持评级并维持其55美元的目标股价之后,Insmed股价走高
Insmed Shares Are Trading Higher After Wells Fargo Maintained an Overweight Rating on the Stock and Maintained Its Price Target of $55
在富国银行维持对该股的增持评级并维持其55美元的目标股价之后,Insmed股价走高
使用浏览器的分享功能,分享给你的好友吧